Funding · Company
SRT Therapeutics, Inc.
San Diego, CABiotech & Pharma
SRT Therapeutics, Inc. of San Diego, CA has disclosed $47M across 1 Form D offering filed with the SEC on Aug 14, 2025.
$47M
Total disclosed
1
Form D offering
2024
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$47M
Form D · Aug 14, 2025 ↗
Q3 2025
· target $48M
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2024SEC CIK0002080322Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →